Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

J Charles Homcy


  • Chairman Of Pharmaceuticals at Bridgebio Pharma Inc. (BBIO), 2020-02-13
  • Other at Portola Pharmaceuticals Inc (PTLA), 2019-04-01
  • Director at Global Blood Therapeutics Inc. (GBT), 2018-06-22
  • Director at Myokardia Inc (MYOK), 2016-12-01
  • Director at Cephalon Inc (CEPH), 2011-10-17
  • Director at Geron Corp (GERN), 2011-05-14
Insider Trading: Sales See All
Company Symbol Price Amount Relationship Remaining Holdings Date Form 4
BBIO $36.00 20,000 Officer, Director 1,342,291 2020-02-10 Filing
BBIO $35.00 10,000 Officer, Director 1,362,291 2020-01-14 Filing
PTLA $19.20 700 Director 112,471 2018-12-17 Filing
PTLA $18.60 63,518 Director 113,171 2018-12-17 Filing
GBT $34.09 15,600 Director 67,728 2017-10-27 Filing